This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Kymera Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Philip Collier
Introduction
Philip Collier is an accomplished inventor based in Watertown, MA. He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds and methods.
Latest Patents
Collier holds a patent for "CDK2 degraders and uses thereof." This invention provides compounds, compositions, and methods for utilizing these degraders, showcasing his innovative approach to addressing complex biological challenges.
Career Highlights
Collier is currently employed at Kymera Therapeutics, Inc., where he continues to push the boundaries of scientific research and development. His work focuses on creating transformative therapies that can improve patient outcomes.
Collaborations
He collaborates with talented colleagues, including Xiaozhang Zheng and Yi Zhang, to advance their shared goals in the field of drug discovery and development.
Conclusion
Philip Collier's contributions to biotechnology through his patent and work at Kymera Therapeutics, Inc. highlight his role as a key innovator in the industry. His ongoing efforts are likely to lead to further advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile